Groupe Novasep

A Unique Business Model and Organization - Innovative Manufacturing Solutions for the Life Science Industries

Novasep brings innovative solutions to complex challenges within the life science industries for the production of synthetic molecules and biomolecules.

In order to fulfill our customers’ ingredient needs, we develop and use a broad portfolio of technologies to support our unique business model:

  • we develop manufacturing solutions,
  • we provide custom manufacturing services (outsourcing solutions),
  • we sell purification processes (in-sourcing solutions).

Our offering helps our customers to enhance product quality, reduce production costs and shorten time-to-market.

To better serve the needs of our customers we operate through three business divisions: Biopharma, Industrial Biotech and Synthesis.

Synthesis BU: uses a large range of chemical synthesis and purification technologies to develop and produce high value-adding active ingredients and advanced intermediates for the pharmaceutical, crop science and other fine chemical industries.

Biopharma BU: supplies upstream and downstream contract manufacturing services to the biopharma industry. It produces innovative purification equipment and systems, with optimized processes, for the biopharmaceutical and fine chemical industries, including the pharmaceutical industry.

Industrial Biotech BU: designs and develops high performance purification processes and industrial systems. It serves the food, functional and bioindustrial ingredients’ industries. This BU also provides contract purification services for functional ingredients.

Download Novasep's corporate presentation (PDF)

With Novasep, you will benefit from our process intelligence:

  • coming from the cross-fertilization of our experience acquired within diverse applications,
  • backed by our expertise in both using and developing our own technologies.

The company has six FDA inspected manufacturing plants in France, Germany and the Bahamas; two biopharmaceutical production sites in Belgium; R&D and equipment manufacturing facilities in the USA, China and France; as well as an office in Japan. Our facilities are further described here.

Novasep employs approximately 1,200 people and had annual revenues of 295 million Euros in 2011. More than 2,000 systems designed and produced by Novasep are currently purifying active molecules throughout the world. The company holds approximately 200 different patents covering its technologies and processes.

Download our brochures for synthetic and bio-molecules.

Contact us  for any synthetic and bio-molecules request.


Novasep Corporate Brochure